HF
NURO

HRT Financial’s NeuroMetrix, Inc. Common Stock NURO Stock Holding History

HRT Financial’s Portfolio NURO Stock Details NURO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3,319
Closed -$25K – 3307
2023
Q2 		$25K Buy
+3,319
New +$30.7K ﹤0.01% 2080

Other funds holding NURO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
TAM
Tucker Asset Management Littleton, Colorado $343M AUM 17.55% 1-Year Est. Return

HRT Financial's NURO Position: Q3 2023 in Review

HRT Financial sold out of NeuroMetrix, Inc. Common Stock (NURO) in Q3 2023, closing a stake of 3,319 shares — an estimated $25K sold.

HRT Financial first reported a position in NURO in Q2 2023 and held it in 1 quarter. The position peaked at $25K in Q2 2023. 14 funds tracked by Wall St. Rank hold NURO as of Q3 2023.

  • HRT Financial reported no remaining NeuroMetrix, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • HRT Financial sold 3,319 NeuroMetrix, Inc. Common Stock shares in Q3 2023, an estimated $25K.
  • HRT Financial first reported a position in NeuroMetrix, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
  • HRT Financial's NeuroMetrix, Inc. Common Stock position peaked at $25K in Q2 2023.
  • 14 funds tracked by Wall St. Rank held NeuroMetrix, Inc. Common Stock as of Q3 2023.

Based on HRT Financial's 13F filing for Q3 2023, filed 13 Nov 2023.